UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)
CUSIP: 90466Y103
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 18,578,488
- Total 13F shares
- 1,115,406
- Share change
- -26,884
- Total reported value
- $2,298,000
- Price per share
- $2.06
- Number of holders
- 9
- Value change
- -$90,197
- Number of buys
- 3
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 90466Y103?
CUSIP 90466Y103 identifies UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90466Y103:
Top shareholders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
3.8%
|
700,000
|
$1,981,000 | — | 30 Sep 2021 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
1.3%
|
247,583
|
$700,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
26,109
|
$73,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
25,551
|
$72,000 | — | 30 Sep 2021 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.11%
|
20,000
|
$57,000 | — | 30 Sep 2021 | |
| Frontier Wealth Management LLC |
13F
|
Company |
0.1%
|
18,838
|
$53,000 | — | 30 Sep 2021 | |
| TANDEM CAPITAL MANAGEMENT CORP /ADV |
13F
|
Company |
0.08%
|
15,500
|
$44,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
11,443
|
$33,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
621
|
$2,000 | — | 30 Sep 2021 |
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q4 2021
As of 31 Dec 2021,
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,115,406 shares.
The largest 9 holders included
Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, Ayrton Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Frontier Wealth Management LLC, BlackRock Inc., TANDEM CAPITAL MANAGEMENT CORP /ADV, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
9
Q4 2021 holders
9
Holder diff
0
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.